한글목차

세계의 지혈 밸브 시장 규모는 2024년에 1억 6,000만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 5.3%로 성장하여 2031년까지 2억 2,800만 달러로 확대될 것으로 예측됩니다.

본 보고서는 최근 지혈밸브에 대한 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업의 발자취, 자본 배분 패턴, 지역경제의 상호의존성, 공급망 재구축 등을 종합적으로 평가합니다.

2024년 세계 지혈 밸브 생산량은 5,528만 개, 세계 평균 시장 가격은 개당 약 2.89달러에 달했습니다. 지혈 밸브는 주로 중재적 심장학 및 혈관성형술에 사용됩니다. 체액 손실과 역류를 최소화하도록 설계되었으며, 다양한 기능을 갖춘 다양한 스타일로 제공됩니다.

지혈 밸브의 단일 생산 라인의 연간 생산능력은 주로 70만-200만 개 범위입니다. 대규모 기업들은 고도로 자동화된 생산라인을 통해 이 능력을 달성하고, 40-50%의 매출총이익률을 유지하면서 수익성을 보장하고 있습니다. 여러 라인을 가동하는 주요 기업들은 연간 수천만 단위의 생산능력을 갖추고 있으며, 세계 시장 점유율의 50% 이상을 차지하고 있습니다. 이러한 생산능력의 우위는 직접적으로 단가를 낮추고 시장에서의 입지를 강화하고 있습니다. 생산능력 배분과 원가관리 능력은 업계의 핵심 경쟁요소로 평균 단가 2.89달러의 시장에서 수익성을 직접적으로 결정짓는 요소입니다.

이 보고서는 지혈 밸브 세계 시장에 대해 총 판매량, 매출, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하여 판매량(천 단위)과 매출액(백만 달러)으로 지혈 밸브 시장 규모와 추정 및 예측을 제시했습니다. 정량적, 정성적 분석을 통해 지혈밸브 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 도와드립니다.

시장 세분화

기업별

• Boston Scientific
• Freudenberg Medical
• Argon Medical
• DeRoyal Industries, Inc.
• Teleflex
• Galt Medical Corp.
• Scitech
• Medtronic
• Excel Medical Products
• Merit Medical Systems
• Elcam Medical
• Abbott

유형별 부문

• 지혈 밸브 Y 커넥터
• 더블 Y 커넥터 지혈 밸브
• 한 손 조작식 지혈 밸브
• 기타

용도별 부문

• 병원
• 진료소

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동 및 아프리카

영문목차

The global market for Hemostatic Valves was estimated to be worth US$ 160 million in 2024 and is forecast to a readjusted size of US$ 228 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hemostatic Valves cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Hemostasis valves production reached 55.28 million untis, with an average global market price of around US$ 2.89 per unit. Hemostasis valves, which is used primarily in interventional cardiology and angioplasty procedures. Designed to minimize fluid loss and backflow, the valves are available in a range of styles with a variety of features.

The annual production capacity of a single hemostasis valve production line predominantly ranges from 700,000 to 2 million units. Large-scale enterprises achieve this capacity through highly automated production lines while maintaining profitability with gross margins of 40% to 50%. Leading companies, utilizing multiple production lines, have established an annual production capacity reaching tens of millions of units, accounting for over 50% of the global market share. Their capacity advantage directly reduces unit production costs and strengthens their market position. Capacity allocation and cost control capabilities have become core competitive factors in the industry, directly determining profitability in a market with an average unit price of $2.89.

This report aims to provide a comprehensive presentation of the global market for Hemostatic Valves, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemostatic Valves by region & country, by Type, and by Application.

The Hemostatic Valves market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Valves.

Market Segmentation

By Company

• Boston Scientific
• Freudenberg Medical
• Argon Medical
• DeRoyal Industries, Inc.
• Teleflex
• Galt Medical Corp.
• Scitech
• Medtronic
• Excel Medical Products
• Merit Medical Systems
• Elcam Medical
• Abbott

Segment by Type

• Hemostasis Valve Y-Connectors
• Double Y-Connector Hemostasis Valves
• One-Handed Hemostasis Valves
• Others

Segment by Application

• Hospitals
• Clinics

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Hemostatic Valves manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Hemostatic Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Hemostatic Valves in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Hemostatic Valves Product Introduction
• 1.2 Global Hemostatic Valves Market Size Forecast
  • 1.2.1 Global Hemostatic Valves Sales Value (2020-2031)
  • 1.2.2 Global Hemostatic Valves Sales Volume (2020-2031)
  • 1.2.3 Global Hemostatic Valves Sales Price (2020-2031)
• 1.3 Hemostatic Valves Market Trends & Drivers
  • 1.3.1 Hemostatic Valves Industry Trends
  • 1.3.2 Hemostatic Valves Market Drivers & Opportunity
  • 1.3.3 Hemostatic Valves Market Challenges
  • 1.3.4 Hemostatic Valves Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Hemostatic Valves Players Revenue Ranking (2024)
• 2.2 Global Hemostatic Valves Revenue by Company (2020-2025)
• 2.3 Global Hemostatic Valves Players Sales Volume Ranking (2024)
• 2.4 Global Hemostatic Valves Sales Volume by Company Players (2020-2025)
• 2.5 Global Hemostatic Valves Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Hemostatic Valves Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Hemostatic Valves Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Hemostatic Valves
• 2.9 Hemostatic Valves Market Competitive Analysis
  • 2.9.1 Hemostatic Valves Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Hemostatic Valves Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Valves as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Hemostasis Valve Y-Connectors
  • 3.1.2 Double Y-Connector Hemostasis Valves
  • 3.1.3 One-Handed Hemostasis Valves
  • 3.1.4 Others
• 3.2 Global Hemostatic Valves Sales Value by Type
  • 3.2.1 Global Hemostatic Valves Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Hemostatic Valves Sales Value, by Type (2020-2031)
  • 3.2.3 Global Hemostatic Valves Sales Value, by Type (%) (2020-2031)
• 3.3 Global Hemostatic Valves Sales Volume by Type
  • 3.3.1 Global Hemostatic Valves Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Hemostatic Valves Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Hemostatic Valves Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Hemostatic Valves Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Clinics
• 4.2 Global Hemostatic Valves Sales Value by Application
  • 4.2.1 Global Hemostatic Valves Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Hemostatic Valves Sales Value, by Application (2020-2031)
  • 4.2.3 Global Hemostatic Valves Sales Value, by Application (%) (2020-2031)
• 4.3 Global Hemostatic Valves Sales Volume by Application
  • 4.3.1 Global Hemostatic Valves Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Hemostatic Valves Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Hemostatic Valves Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Hemostatic Valves Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Hemostatic Valves Sales Value by Region
  • 5.1.1 Global Hemostatic Valves Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Hemostatic Valves Sales Value by Region (2020-2025)
  • 5.1.3 Global Hemostatic Valves Sales Value by Region (2026-2031)
  • 5.1.4 Global Hemostatic Valves Sales Value by Region (%), (2020-2031)
• 5.2 Global Hemostatic Valves Sales Volume by Region
  • 5.2.1 Global Hemostatic Valves Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Hemostatic Valves Sales Volume by Region (2020-2025)
  • 5.2.3 Global Hemostatic Valves Sales Volume by Region (2026-2031)
  • 5.2.4 Global Hemostatic Valves Sales Volume by Region (%), (2020-2031)
• 5.3 Global Hemostatic Valves Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Hemostatic Valves Sales Value, 2020-2031
  • 5.4.2 North America Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Hemostatic Valves Sales Value, 2020-2031
  • 5.5.2 Europe Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Hemostatic Valves Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Hemostatic Valves Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Hemostatic Valves Sales Value, 2020-2031
  • 5.7.2 South America Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Hemostatic Valves Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Hemostatic Valves Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Hemostatic Valves Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Hemostatic Valves Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Hemostatic Valves Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Hemostatic Valves Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Hemostatic Valves Sales Value, 2020-2031
  • 6.3.2 United States Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Hemostatic Valves Sales Value, 2020-2031
  • 6.4.2 Europe Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Hemostatic Valves Sales Value, 2020-2031
  • 6.5.2 China Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Hemostatic Valves Sales Value, 2020-2031
  • 6.6.2 Japan Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Hemostatic Valves Sales Value, 2020-2031
  • 6.7.2 South Korea Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Hemostatic Valves Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Hemostatic Valves Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Hemostatic Valves Sales Value, 2020-2031
  • 6.9.2 India Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Hemostatic Valves Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Boston Scientific
  • 7.1.1 Boston Scientific Company Information
  • 7.1.2 Boston Scientific Introduction and Business Overview
  • 7.1.3 Boston Scientific Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Boston Scientific Hemostatic Valves Product Offerings
  • 7.1.5 Boston Scientific Recent Development
• 7.2 Freudenberg Medical
  • 7.2.1 Freudenberg Medical Company Information
  • 7.2.2 Freudenberg Medical Introduction and Business Overview
  • 7.2.3 Freudenberg Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Freudenberg Medical Hemostatic Valves Product Offerings
  • 7.2.5 Freudenberg Medical Recent Development
• 7.3 Argon Medical
  • 7.3.1 Argon Medical Company Information
  • 7.3.2 Argon Medical Introduction and Business Overview
  • 7.3.3 Argon Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Argon Medical Hemostatic Valves Product Offerings
  • 7.3.5 Argon Medical Recent Development
• 7.4 DeRoyal Industries, Inc.
  • 7.4.1 DeRoyal Industries, Inc. Company Information
  • 7.4.2 DeRoyal Industries, Inc. Introduction and Business Overview
  • 7.4.3 DeRoyal Industries, Inc. Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 DeRoyal Industries, Inc. Hemostatic Valves Product Offerings
  • 7.4.5 DeRoyal Industries, Inc. Recent Development
• 7.5 Teleflex
  • 7.5.1 Teleflex Company Information
  • 7.5.2 Teleflex Introduction and Business Overview
  • 7.5.3 Teleflex Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Teleflex Hemostatic Valves Product Offerings
  • 7.5.5 Teleflex Recent Development
• 7.6 Galt Medical Corp.
  • 7.6.1 Galt Medical Corp. Company Information
  • 7.6.2 Galt Medical Corp. Introduction and Business Overview
  • 7.6.3 Galt Medical Corp. Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Galt Medical Corp. Hemostatic Valves Product Offerings
  • 7.6.5 Galt Medical Corp. Recent Development
• 7.7 Scitech
  • 7.7.1 Scitech Company Information
  • 7.7.2 Scitech Introduction and Business Overview
  • 7.7.3 Scitech Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Scitech Hemostatic Valves Product Offerings
  • 7.7.5 Scitech Recent Development
• 7.8 Medtronic
  • 7.8.1 Medtronic Company Information
  • 7.8.2 Medtronic Introduction and Business Overview
  • 7.8.3 Medtronic Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Medtronic Hemostatic Valves Product Offerings
  • 7.8.5 Medtronic Recent Development
• 7.9 Excel Medical Products
  • 7.9.1 Excel Medical Products Company Information
  • 7.9.2 Excel Medical Products Introduction and Business Overview
  • 7.9.3 Excel Medical Products Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Excel Medical Products Hemostatic Valves Product Offerings
  • 7.9.5 Excel Medical Products Recent Development
• 7.10 Merit Medical Systems
  • 7.10.1 Merit Medical Systems Company Information
  • 7.10.2 Merit Medical Systems Introduction and Business Overview
  • 7.10.3 Merit Medical Systems Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Merit Medical Systems Hemostatic Valves Product Offerings
  • 7.10.5 Merit Medical Systems Recent Development
• 7.11 Elcam Medical
  • 7.11.1 Elcam Medical Company Information
  • 7.11.2 Elcam Medical Introduction and Business Overview
  • 7.11.3 Elcam Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Elcam Medical Hemostatic Valves Product Offerings
  • 7.11.5 Elcam Medical Recent Development
• 7.12 Abbott
  • 7.12.1 Abbott Company Information
  • 7.12.2 Abbott Introduction and Business Overview
  • 7.12.3 Abbott Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Abbott Hemostatic Valves Product Offerings
  • 7.12.5 Abbott Recent Development

8 Industry Chain Analysis

• 8.1 Hemostatic Valves Industrial Chain
• 8.2 Hemostatic Valves Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Hemostatic Valves Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Hemostatic Valves Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer